Patent · US Active

Methods for assessing binding affinity of an antibody variant to the neonatal Fc receptor

US12172106B2 · kind B2 · utility

0Cited by
0References
23Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 8, 2019
Grant dateDec 24, 2024
Priority date
Expiry dateFeb 23, 2042

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2030/027
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

The present invention provides methods to quickly and efficiently assess the effect of antibody variants, including PTMs, e.g., glycosylation, oxidation, and deamidation variants, on the binding between the antibody and FcRn. In particular, the present invention is based, at least in part, on the development of an online, two dimension liquid chromatography (2D-LC) method for assessing binding between antibody variants and FcRn. In one aspect, the online 2D-LC is coupled with mass spectrometry (MS). The present invention allows for differentiation of antibody variants by peak pattern and retention time profile by affinity chromatography, and identification of these variants by mass spectrometry analysis.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.